as a marker of heterogeneity within FS cells, establishing a foundation for future studies on GPR37L1 signaling in pituitary microenvironmental regulation.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: